DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Thalomid (Thalidomide) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Death (25)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Thalomid (Thalidomide) where reactions include death. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Thalomid side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-15

Patient: male

Reactions: Death, Unevaluable Event

Adverse event resulted in: death

Drug(s) suspected as cause:
Thalomid



Possible Thalomid side effects in

Reported by a individual with unspecified qualification from Spain on 2012-07-30

Patient:

Reactions: Colon Cancer, Pulmonary Embolism, Toxicity To Various Agents, Multiple Myeloma, Herpes Zoster, Death, Neuropathy Peripheral, Gastrointestinal Disorder, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1.3mg/m2 on days 1,4,8 and 11 q 3 weeks
    Indication: Multiple Myeloma

Thalomid
    Dosage: 200mg daily (escalating doses in the first cycle)
    Administration route: Oral
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40mg on days 1-4 and 9-12 at 4-week intervals
    Administration route: Oral
    Indication: Multiple Myeloma



Possible Thalomid side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Thalomid
    Dosage: 50 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-06-19

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-06-15

Other drugs received by patient: Aspirin



Possible Thalomid side effects in female

Reported by a pharmacist from Canada on 2012-07-18

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-04-19

Thalomid
    Dosage: 50 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-17



Possible Thalomid side effects in

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-07-16

Patient:

Reactions: Graft Versus Host Disease, Pulmonary Embolism, Toxicity To Various Agents, Polyneuropathy, Disease Progression, Death, Embolism Venous, Deep Vein Thrombosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Thalomid
    Dosage: induction therapy, 200 mg escalated to 400 mg, qd, with vte prophylaxis
    Administration route: Oral
    Indication: Multiple Myeloma

Melphalan Hydrochloride
    Dosage: 200 milligram/sq. meter

Cyclophosphamide
    Dosage: 1000 milligram/sq. meter
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral

Adriamycin PFS
    Dosage: 15 milligram/sq. meter

Thalomid
    Dosage: maintenance therapy, 50 mg qd, without vte prophylaxis
    Administration route: Oral

Adriamycin PFS
    Dosage: 9 milligram/sq. meter
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen; Mycophenolate Mophetil; Cyclosporine; Nadroparine



Possible Thalomid side effects in male

Reported by a physician from United States on 2012-06-26

Patient: male

Reactions: Death, Renal Disorder, Platelet Count Decreased, Full Blood Count Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Thalomid
    Dosage: 100 milligram
    Administration route: Oral
    Start date: 2010-12-01

Thalomid
    Dosage: 100 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-10-01

Other drugs received by patient: Alkeran; Whole Blood; Dexamethasone; Acyclovir; Neupogen; Platelets; Velcade; Vorinostat



Possible Thalomid side effects in male

Reported by a pharmacist from Australia on 2012-06-04

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Revlimid
    Administration route: Oral
    Start date: 2012-01-20

Thalomid
    Dosage: 50 milligram
    Administration route: Oral
    Start date: 2011-08-12



Possible Thalomid side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-16

Patient: male

Reactions: Death, Haemoptysis, Rash Pruritic

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-08-02

Etoposide
    Dosage: unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-08-29

Thalomid
    Dosage: 100 mg, qd
    Administration route: Oral
    Start date: 2010-10-01

Thalomid
    Dosage: 100 mg, qd
    Administration route: Oral
    Start date: 2011-07-01

Thalomid
    Dosage: 100 mg, qd
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-09-01

Thalomid
    Dosage: 100 unk, unk
    Administration route: Oral
    Start date: 2011-06-01

Velcade
    Dosage: unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-08-29

Adriamycin PFS
    Dosage: unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-08-29

Dexamethasone
    Dosage: unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-08-29

Other drugs received by patient: Melphalan Hydrochloride



Possible Thalomid side effects in male

Reported by a physician from United States on 2012-05-15

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2008-02-14
    End date: 2012-03-09

Thalomid
    Dosage: 100 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-03-24



Possible Thalomid side effects in female

Reported by a consumer/non-health professional from United States on 2012-04-24

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Thalomid
    Dosage: 200 milligram
    Administration route: Oral
    Start date: 2010-08-01

Thalomid
    Dosage: 200 milligram
    Administration route: Oral
    Start date: 2011-03-01

Thalomid
    Dosage: 200 milligram
    Administration route: Oral
    Start date: 2011-10-01

Thalomid
    Dosage: 400 milligram
    Administration route: Oral
    Start date: 2010-09-01

Thalomid
    Dosage: 200 milligram
    Administration route: Oral
    Start date: 2011-12-01

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2012-03-01

Thalomid
    Dosage: 200 milligram
    Administration route: Oral
    Start date: 2010-12-01

Thalomid
    Dosage: 100 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2008-11-01

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-02-01

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2011-11-01

Thalomid
    Dosage: 400 milligram
    Administration route: Oral
    Start date: 2012-04-01

Thalomid
    Dosage: 200 milligram
    Administration route: Oral
    Start date: 2011-05-01

Thalomid
    Dosage: 50 milligram
    Administration route: Oral
    Start date: 2011-07-01



Possible Thalomid side effects in female

Reported by a consumer/non-health professional from United States on 2012-04-09

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Thalomid
    Dosage: 100 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2008-11-01

Thalomid
    Dosage: 400 milligram
    Administration route: Oral
    Start date: 2010-09-01

Thalomid
    Dosage: 200 milligram
    Administration route: Oral
    Start date: 2010-12-01

Thalomid
    Dosage: 200 milligram
    Administration route: Oral
    Start date: 2011-05-01

Thalomid
    Dosage: 200 milligram
    Administration route: Oral
    Start date: 2011-10-01

Thalomid
    Dosage: 200 milligram
    Administration route: Oral
    Start date: 2010-08-01

Thalomid
    Dosage: 200 milligram
    Administration route: Oral
    Start date: 2011-03-01

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-02-01

Thalomid
    Dosage: 50 milligram
    Administration route: Oral
    Start date: 2011-07-01

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2011-11-01

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2012-03-01

Thalomid
    Dosage: 400 milligram
    Administration route: Oral
    Start date: 2012-04-01

Thalomid
    Dosage: 200 milligram
    Administration route: Oral
    Start date: 2011-12-01



Possible Thalomid side effects in

Reported by a physician from United States on 2012-04-02

Patient:

Reactions: Gastrointestinal Toxicity, Disease Progression, Haematotoxicity, Death, Hepatobiliary Disease, Metabolic Disorder, Electrolyte Imbalance, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Thalomid
    Dosage: 50 milligram
    Administration route: Oral

Thalomid
    Dosage: 50 milligram
    Administration route: Oral

Dexamethasone
    Dosage: 12 milligram

Melphalan Hydrochloride
    Dosage: 5 milligram/sq. meter

Cyclophosphamide
    Dosage: 75 microgram/sq. meter

Thalomid
    Dosage: 100 milligram
    Administration route: Oral

Melphalan Hydrochloride
    Dosage: 10 milligram/sq. meter
    Indication: Multiple Myeloma

Melphalan Hydrochloride
    Dosage: 20 milligram/sq. meter

Doxorubicin HCL
    Dosage: 10 microgram/sq. meter

Cyclophosphamide
    Dosage: 75 microgram/sq. meter

Bortezomib
    Dosage: 1 milligram/sq. meter
    Indication: Multiple Myeloma

Bortezomib
    Dosage: 1 milligram/sq. meter

Bortezomib
    Dosage: 1.3 milligram/sq. meter

Bortezomib
    Dosage: 1.3 milligram/sq. meter

Dexamethasone
    Dosage: 20 milligram

Dexamethasone
    Dosage: 40 milligram

Melphalan Hydrochloride
    Dosage: 4 milligram/sq. meter

Cisplatin
    Dosage: 75 microgram/sq. meter

Doxorubicin HCL
    Dosage: 10 microgram/sq. meter
    Indication: Multiple Myeloma

Doxorubicin HCL
    Dosage: 75 microgram/sq. meter

Revlimid
    Dosage: 25 milligram
    Administration route: Oral

Thalomid
    Dosage: 100 milligram
    Administration route: Oral

Dexamethasone
    Dosage: 20 milligram

Melphalan Hydrochloride
    Dosage: 5 milligram/sq. meter

Cisplatin
    Dosage: 10 microgram/sq. meter
    Indication: Multiple Myeloma

Cyclophosphamide
    Dosage: 100 microgram/sq. meter

Etoposide
    Dosage: 60 microgram/sq. meter

Revlimid
    Dosage: 15 milligram
    Administration route: Oral

Bortezomib
    Dosage: 1 milligram/sq. meter

Dexamethasone
    Dosage: 20 milligram

Cisplatin
    Dosage: 75 microgram/sq. meter

Cyclophosphamide
    Dosage: 100 microgram/sq. meter

Etoposide
    Dosage: 80 microgram/sq. meter

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Thalomid
    Dosage: 50 milligram
    Administration route: Oral

Dexamethasone
    Dosage: 40 milligram
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40 milligram

Dexamethasone
    Dosage: 20 milligram

Cisplatin
    Dosage: 10 microgram/sq. meter

Cisplatin
    Dosage: 10 microgram/sq. meter

Doxorubicin HCL
    Dosage: 75 microgram/sq. meter

Cyclophosphamide
    Dosage: 400 microgram/sq. meter
    Indication: Multiple Myeloma

Etoposide
    Dosage: 40 microgram/sq. meter
    Indication: Multiple Myeloma

Thalomid
    Dosage: 200 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Thalomid
    Dosage: 50 milligram
    Administration route: Oral

Dexamethasone
    Dosage: 20 milligram

Melphalan Hydrochloride
    Dosage: 20 milligram/sq. meter

Etoposide
    Dosage: 80 microgram/sq. meter

Thalomid
    Dosage: 50 milligram
    Administration route: Oral

Bortezomib
    Dosage: 1.3 milligram/sq. meter

Dexamethasone
    Dosage: 20 milligram

Dexamethasone
    Dosage: 20 milligram

Doxorubicin HCL
    Dosage: 10 microgram/sq. meter

Etoposide
    Dosage: 60 microgram/sq. meter



Possible Thalomid side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-30

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Thalomid
    Dosage: 50 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-08-13

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-11-25

Thalomid
    Dosage: 100 milligram
    Administration route: Oral
    Start date: 2010-11-01

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2008-04-07
    End date: 2008-06-10

Other drugs received by patient: Dilaudid; Vitamin B-12; Vitamin E; Lorazepam; Phosphate LAX; Gabapentin; Lidocaine; Olanzapine; Dexamethasone; Acyclovir; Mirtazapine; Nephro Vite



Possible Thalomid side effects in female

Reported by a physician from United States on 2012-03-22

Patient: female

Reactions: Death, Drug Ineffective, Splenomegaly

Adverse event resulted in: death

Drug(s) suspected as cause:
Thalomid
    Dosage: 100 milligram
    Administration route: Oral
    Start date: 2010-09-01

Thalomid
    Dosage: 100 milligram
    Administration route: Oral
    Start date: 2010-06-01

Thalomid
    Dosage: 200 milligram
    Administration route: Oral
    Indication: Myelodysplastic Syndrome
    Start date: 2009-06-01



Possible Thalomid side effects in male

Reported by a consumer/non-health professional from United States on 2012-02-17

Patient: male

Reactions: Death, Femur Fracture, Urticaria, Haematemesis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Thalomid

Other drugs received by patient: Opium



Possible Thalomid side effects in female

Reported by a physician from United States on 2012-02-06

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Thalomid
    Dosage: 200 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-06-01

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2008-12-01

Revlimid
    Dosage: 20 milligram
    Administration route: Oral
    Start date: 2009-02-01

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2009-03-01

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2009-06-01

Other drugs received by patient: Antibiotics



Possible Thalomid side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-06

Patient:

Reactions: Death, Multiple Myeloma

Adverse event resulted in: death

Drug(s) suspected as cause:
Revlimid
    Administration route: Oral
    Indication: Multiple Myeloma

Thalomid
    Administration route: Oral
    Indication: Multiple Myeloma

Other drugs received by patient: Bortezomib



Possible Thalomid side effects in female

Reported by a physician from United States on 2012-02-03

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2008-12-01

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2009-03-01

Thalomid
    Dosage: 200 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-06-01

Revlimid
    Dosage: 20 milligram
    Administration route: Oral
    Start date: 2009-02-01

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2009-06-01

Other drugs received by patient: Antibiotics



Possible Thalomid side effects in female

Reported by a physician from United States on 2012-02-02

Patient: female

Reactions: Death, Subdural Haematoma, Fracture, Fall

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Thalomid



Possible Thalomid side effects in female

Reported by a physician from United States on 2012-01-19

Patient: female

Reactions: Death, Subdural Haematoma, Fracture, Fall

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Thalomid



Possible Thalomid side effects in female

Reported by a physician from United States on 2012-01-09

Patient: female

Reactions: Death, Subdural Haematoma, Fall

Adverse event resulted in: death

Drug(s) suspected as cause:
Thalomid



Possible Thalomid side effects in female

Reported by a physician from United States on 2011-12-29

Patient: female, weighing 81.3 kg (178.8 pounds)

Reactions: Death, Pathological Fracture

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Thalomid
    Dosage: 200-50mg
    Administration route: Oral
    Start date: 2009-11-01

Thalomid
    Dosage: 100 milligram
    Administration route: Oral
    Start date: 2011-05-01

Thalomid
    Dosage: 100 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-11-01

Thalomid
    Dosage: 200 milligram
    Administration route: Oral
    Start date: 2011-11-01

Other drugs received by patient: Oxycodone HCL; Xanax; Velcade; Oxycontin; Oxycontin; Morphine Sulfate; Dexamethasone



Possible Thalomid side effects in female

Reported by a consumer/non-health professional from United States on 2011-11-07

Patient: female

Reactions: Death, Renal Disorder, Pneumonia

Adverse event resulted in: death

Drug(s) suspected as cause:
Thalomid
    Dosage: 150-50mg
    Administration route: Oral
    Start date: 2010-01-01

Thalomid
    Dosage: 100 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-11-01

Thalomid
    Dosage: 200 milligram
    Administration route: Oral
    Start date: 2010-04-01

Thalomid
    Dosage: 100 milligram
    Administration route: Oral
    Start date: 2011-07-01



Possible Thalomid side effects in female

Reported by a physician from United States on 2011-10-19

Patient: female

Reactions: Death, Multiple Myeloma

Adverse event resulted in: death

Drug(s) suspected as cause:
Thalomid
    Dosage: 100 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-08-01
    End date: 2011-01-01

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-08-01
    End date: 2011-01-01

Other drugs received by patient: Velcade; Valtrex; Decadron; Zometa; Zofran; Aspirin



Possible Thalomid side effects in male

Reported by a physician from United States on 2011-10-19

Patient: male

Reactions: Back Pain, Jaundice, Death, Arthralgia, Musculoskeletal Chest Pain

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Thalomid

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017